Cabbacis (OTCQB: CABI) is pioneering harm-reduction in the global tobacco industry, targeting the world’s one billion smokers with its flagship iBlend™ line of reduced-nicotine cigarettes and compatible vaporizer pods. These proprietary, patent protected products combine ultra-low‑nicotine tobacco with non-intoxicating hemp, helping smokers on their nicotine quitting journey. Proven in studies and backed by 35 issued patents worldwide covering the combination of hemp and low-nicotine tobacco in a cigarette, Cabbacis holds a strong IP position ahead of a proposed FDA requirement to lower nicotine levels by 95% in all cigarettes across the United States. To learn more, please visit cabbacis.com.
Company Details
- Employees
- 2
- Industry
- Tobacco Manufacturing
- NAICS
-
Tobacco Manufacturing
- Website
- http://www.cabbacis.com
- Keywords
- Buffalo.
Cabbacis Questions
Cabbacis's website is http://www.cabbacis.com
Cabbacis's LinkedIn profile is https://www.linkedin.com/company/cabbacis
Cabbacis has
2 employees.
View email and phone details for 2
employees at Cabbacis.
Cabbacis's industry is
Tobacco Manufacturing
Cabbacis's top competitors are
Jag Media,
Statdash Llc,
Arch & Type,
Nexscient™,
Institute For Clinical Pharmacodynamics,
Sonmax Entertainment, Llc,
Tell Consulting,
Splendid Strategy,
Buffalo General Dentistry,
Thepro Nextdoor.
Cabbacis's categories are Tobacco Manufacturing
